Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing – V 2.0

Standard Operating Procedure for Sampling Procedures during Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/074/2025
Supersedes SOP/SIM/074/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standardized method for the collection of representative samples during various stages of sterile injectable manufacturing for testing and evaluation, ensuring regulatory compliance and product quality.

2. Scope

This SOP applies to all sterile injectable manufacturing activities at [Insert Company Name] where in-process, intermediate, and finished product

samples are collected for analysis and quality evaluation.

3. Responsibilities

  • Production Officer: Responsible for collecting samples as per defined plan.
  • IPQA Officer: Verifies correct sampling, labels, and documentation.
  • QC Analyst: Receives samples and performs required tests.
See also  Sterile Injectable Manufacturing: SOP for Ensuring Tamper Evidence in Injectable Packaging - V 2.0

4. Accountability

The Head – Quality Assurance is accountable for overall compliance and ensuring sampling procedures are followed during manufacturing operations.

5. Procedure

5.1 Sampling Plan

  1. Sampling must be performed based on approved sampling plan and batch manufacturing record (BMR).
  2. Sampling stages may include:
    • Raw material sampling
    • In-process bulk sampling
    • Post-filtration sample
    • Finished product sample
    • Environmental and rinse water sample

5.2 Sample Collection Procedure

  1. Ensure clean and sterile containers for sample collection.
  2. Use sterile tools (pipettes, sampling needles) and handle with gloves.
  3. Label each sample immediately with:
    • Batch No.
    • Sample Type
    • Date/Time
    • Sampler Name
  4. Enter sample details in the Sampling Logbook (Annexure-1).
  5. Transfer the samples promptly to the Quality Control laboratory.

5.3 Sample Labeling

  1. Use pre-printed or computer-generated labels where applicable.
  2. Ensure clear legibility and tamper-evident labeling.
See also  Manufacturing Validation: SOP for Validation of Sterilization Cycle in Manufacturing - V 2.0

5.4 Sampling Precautions

  1. Do not sample from damaged or leaking containers/vials.
  2. Ensure aseptic techniques are used during all sampling.
  3. Avoid cross-contamination between samples.

5.5 Sample Quantities

  1. Follow BMR or SOP-defined quantity for each sample type.
  2. Minimum quantity must be sufficient for complete testing and retention sample (if applicable).

5.6 Documentation

  1. All samples must be recorded in the Sampling Logbook and annexure forms.
  2. Details to be entered include:
    • Date and Time
    • Sampler Name
    • Batch and Sample Details

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record

7. Documents

  1. Sampling Logbook – Annexure-1
  2. Sample Label Template – Annexure-2
  3. Sample Transfer Form – Annexure-3

8. References

  • WHO TRS 986 Annex 2: GMP for Sterile Products
  • ICH Q7: GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Current Good Manufacturing Practice
See also  Sterile Injectable Manufacturing: SOP for Conducting Identity Tests on Sterile Products - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Sampling Logbook

Date Batch No. Sample Type Quantity Sampler Name Remarks
18/06/2025 INJ-BT-3021 In-process 20 mL Rajesh Kumar Complies

Annexure-2: Sample Label Template

Label Field Example Entry
Sample Type Bulk Solution
Batch No. INJ-BT-3021
Date 18/06/2025
Sampler Sunita Reddy

Annexure-3: Sample Transfer Form

Date Sample Type Transferred By Received By QC Comments
18/06/2025 Post-filtration Rajesh Kumar Vinay Pawar Accepted

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
18/06/2025 2.0 Updated documentation and annexures Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Compressed Air Quality Verification – V 2.0
Next Post: Elixir Department: SOP for Use of Data Loggers for Process Validation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version